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Abstract
Background: Mutations in the GCH1 gene are associated with childhood onset, dopa-responsive dystonia (DRD).
Correct diagnosis of DRD is crucial, given the potential for complete recovery once treated with L-dopa. The majority
of DRD associated mutations lie within the coding region of the GCH1 gene, but three additional single nucleotide
sequence substitutions have been reported within the 5’ untranslated (5’UTR) region of the mRNA. The biologic
significance of these 5’UTR GCH1 sequence substitutions has not been analyzed.
Methodology/Principal Findings: Luciferase reporter assays, quantitative real time PCR and RNA decay assays,
combined with bioinformatics, revealed a pathogenic 5’UTR GCH1 substitution. The +142C>T single nucleotide
5’UTR substitution that segregates with affected status in DRD patients, substantially attenuates translation without
altering RNA expression levels or stability. The +142C>T substitution disrupts translation most likely by creating an
upstream initiation start codon (uAUG) and an upstream open reading frame (uORF).
Conclusions/Significance: This is the first GCH1 regulatory substitution reported to act at a post-transcriptional
level, increasing the list of genetic diseases caused by abnormal translation and reaffirming the importance of
investigating potential regulatory substitutions in genetic diseases.
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Introduction
Dopa-responsive dystonia (DRD) was first described by
Segawa et al. [1]. It is a movement disorder of childhood onset,
typically beginning in a foot followed by spread, over several
years, to involve other limbs, rendering walking difficult. DRD
displays a diurnal fluctuation with increasing severity over the
course of the day and a marked, sustained response to low
therapeutic doses of levodopa. However, diagnosis remains a
challenge with many cases being misdiagnosed as cerebral
palsy or spastic diplegia.
DRD is frequently caused by heterozygous mutations in the
guanosine triphosphate (GTP) cyclohydrolase 1 gene (GCH1)
[2,3], with this form of dystonia now referred to as DYT5 [4].
GTP cyclohydrolase 1 catalyzes the first step in the
biosynthesis of (BH4). BH4 is a cofactor for three aromatic
amino acid hydroxylases, including tyrosine hydroxylase (TH),
which is the rate-limiting enzyme in dopamine biosynthesis [5].
Thus, low levels of BH4, due to mutations in the GCH1 gene,
can lead to a reduction in dopamine synthesis and dysfunction
of dopaminergic nigrostriatal neurochemical transmission [6].
To date, 114 different mutations have been identified in the
GCH1 gene in patients with DRD (http://www.biopku.org/
authorisation/login.asp) involving, in their majority, missense
and nonsense mutations in all 6 six exons [2,3,7–11], as well
as large or multiexonic deletions and exon frameshifts [12–15].
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Noncoding GCH1 mutations have also been reported spanning
its 5’ upstream region [16–18] and intron-exon splice sites
[19–21]. Within the 5’ upstream region of the human GCH1
gene, three different single base pair (bp) substitutions have
been identified at positions -22C>T [16,18], -39C>T and
-132T>C [17], relative to the GCH1 translation start codon
(ATG), in DRD individuals who lack mutations in the coding
region (Figure 1). As the GCH1 transcription start site has been
identified, we have now demarcated the substitutions relative to
the GCH1 transcription start site (+1) to be in accordance with
revised genetic nomenclature. Thus, the -22C>T substitution is
referred to as +142C>T, the -39C>T as +125C>T and the
-132T>C as +32T>C. The +125C>T and +32T>C substitutions
were identified as co-existing in cis in a single subject with
DRD [17], making it impossible to independently determine
hereditary disease association for each substitution. The
+142C>T substitution has been identified in two different
reports, one of a single individual with DRD [16] and another in
multiple generations of a family with DRD, in whom the
+142C>T substitution segregated with affected status [18].
Whether any of these single nucleotide substitutions have an
impact on GCH1 expression levels has not been investigated.
In the present paper, we demonstrated that among the three
aforementioned 5’UTR GCH1 substitutions, only the +142C>T
is a functional substitution that decreases protein expression.
However, neither mRNA level nor stability were affected by this
substitution. The 5’UTR mediated regulation of translation may
reflect alterations in secondary RNA structure, changes in RNA
binding motifs (RBPs) and associated proteins, or the creation
of upstream open reading frames (uORFs) [22–25]. The
+142C>T substitution within the GCH1 5’UTR introduces an
upstream AUG (uAUG) that potentially creates an out-of-frame
uORF. This uORF partially overlaps with the physiological ORF
(pORF) and likely acts in a competitive manner to down
regulate translation. To our knowledge, this is the first report of
a translational disruption causing DRD or any other type of
dystonia.
Methods
Cell cultures
The human neuroblastoma cell line SK-N-BE(2)-M17 was
purchased from ATCC (Manassas, VA) and maintained in
MEM/F-HAM, supplemented with 10% fetal bovine serum and
1% penicillin/streptomycin, at 37°C and 5% CO2. Lymphocytes
isolated from DRD patients and healthy individuals were
Epstein Barr Virus (EBV) - transformed to stable cell lines, as
previously described [26] and maintained in RPMI 1640 with
5% fetal calf serum, 1% penicillin/streptomycin and 2 mM
glutamine at 37°C and 5% CO2.
Patients and controls
Lymphoblastoid cultures were established from 10 family
members, spanning three generations, in whom the +142C>T
substitution segregated with affected status [18]. Six subjects
Figure 1.  Alignment of the human, mouse and rat 5′ upstream GCH1 regions.  Nucleotides are numbered from the
transcription start site (+1) as previously identified for the human (top), rat (middle) and mouse (bottom) GCH1 genes. Position of
each GCH1 5’UTR substitution identified to date is shaded and the nucleotide substitution is shown beneath the sequence. An
asterisk (*) indicates sequence identity across the three species.
doi: 10.1371/journal.pone.0076975.g001
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were heterozygous for the +142 SNP (C/T) and met the clinical
criteria for DRD [7], while the remaining four family members
were homozygous for the +142C nucleotide (C/C) and had no
evidence of dystonia or other basal ganglia dysfunction on
examination. Two additional control samples (+142C/C) were
utilized from the discarded sample collection of the
Massachusetts General Hospital Neurogenetics DNA
Diagnostic Laboratory. Full GCH1 gene sequencing (exons
1-6), including intron/exon junctions was performed for all
samples and no other nucleotide changes were found [18]. The
local institutional review board approved the study. All
participants gave informed consent.
Reporter constructs and mutagenesis
Human GCH1 luciferase reporter constructs have been
previously described [9]. We utilized a 615 bp and a 5399 bp 5’
upstream GCH1 fragment linked to the firefly luciferase (Fluc)
cDNA in the promoter-less basic Picca Gene Basic Vector 2
(PGV-B2) (Toyo Ink Co., Ltd, Tokyo) [27] referred to as
615GCH1/WT (wild type) and 5399GCH1/WT, respectively
(Figure 2A & 2C). Mutant reporter constructs were generated
from the parental 615GCH1/WT by replacing the +142C with a
T (615GCH1/+142T), the +125C with a T (615GCH1/+125T),
the +32T with a C (615GCH1/+32C), the +125C with a T and
the +32T with a C in the same construct (615GCH1/+125T/
+32C) (Figure 2A). A mutant reporter construct was generated
from the parental 5399GCH1/WT by replacing the +142C with
a T (5399GCH1/+142T) (Figure 2C). All mutant products were
generated using the QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA) and appropriate sets of primers
(sequences available upon request). All constructs were
confirmed by DNA sequencing.
Transfections and luciferase assays
Transient transfections were performed using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) in 1.0 to 1.5 x 106 cells/well
plated onto 24-well tissue culture plates. For each Fluc reporter
construct used in transfections, two independent plasmid Maxi-
preps (Qiagen, Valencia, CA) were used. Each transfection
consisted of 0.8 μg DNA of Fluc reporter construct and 0.4 μg
CMV-Renilla luciferase (Rluc) vector bearing Rluc under the
cytomegalovirus (CMV) promoter, as an internal control of
transfection efficiency (Promega, Madison, WI). Luciferase
activity was analyzed 40 hrs post-transfection, using a dual
luciferase reporter kit (Promega) and a luminometer (Dynex,
Richfield, NM). Luciferase assays were repeated at least four
times, and within each experiment each construct was
transfected in quadruplicate. Results were expressed as a
mean of quadruplicate measures (+ S.E.M.) of Fluc normalized
to Rluc activity. Statistical significance was determined by
Student’s t-test, comparing the activity of each mutant
construct with the wild type parental construct.
Quantitative real-time PCR
RNA was isolated from SK-N-BE(2)-M17 cells transfected
with the 615GCH1/WT or the 615GCH1/+142T construct or
from 5.0 x 106 human lymphoblastoid cells using the miRNA
purification kit (Qiagen) and then subjected to DNase treatment
(Qiagen). Two hundred ng of RNA was then reverse
transcribed using Omniscript (Qiagen) and qPCR reactions
were performed in a 25 µl reaction mixture using Power
SYBR® Green PCR Master Mix (Applied Biosystems, Foster
City, CA) and 160 nM of each primer. Amplification conditions
consisted of: (1) 1 cycle of 50°C, 2 min; (2) 1 cycle of 95°C, 10
min; (3) 40 cycles of 95°C, 15 sec; and 60°C, 1 min, and (4) 1
cycle of 95°C, 15 sec; 60°C, 20 sec; and 95°C, 15 sec, run on
the 7000 ABI Prism PCR system (Applied Biosystems). Fluc
cycle threshold (Ct) values were normalized to Rluc while the
GCH1 Ct values were normalized to the housekeeping gene
hypoxanthine phosphoribosyltransferase 1 (HPRT1).
Normalized Ct values were then converted to relative mRNA
levels. All qRT-PCRs were repeated 4 times for each gene and
each sample was done in triplicate. Primer dimers were
excluded by evaluation of dissociation curve and agarose gel
electrophoresis. Primer sequences were as follows: Rluc
forward- GATAACTGGTCCGCAGTGGT and reverse –
ACCAGATTTGCCTGATTTGC; Fluc forward-
ATCCATCTTGCTCCAACACC and reverse –
TTTTCCGTCATCGTCTTTCC; GCH1 forward
CCTACTCGTCCATCCTGAGC and reverse
GGACCTTTCCAACAAATGGA; HPRT1 forward
TGACACTGGCAAAACAATGCA and reverse
GGTCCTTTTCACCAGCAAAGCT. For mRNA decay assays,
24hrs post-transfection, SK-N-BE(2)-M17 cells were
supplemented with ActinomycinD (5µM/ml, Sigma-Aldrich, St.
Louis, MO) and RNA was extracted at 0, 2, 4 and 6hrs while
lymphoblastoid cultures were treated with ActinomycinD
(5µM/ml) for 0, 6, 12 and 24hrs. Normalized Ct values were
converted to relative mRNA levels, set to 100% for t=0. Decay
kinetics were obtained using linear regression analysis and the
half life for each examined mRNA was calculated based on the
slope and the intercept. The mRNA decay assays were
repeated 3 times for each case, results were expressed as the
mean ± S.E.M. and statistical significance was determined
using Student’s t-test.
Bioinformatics Analysis
Alignment of the 5’ upstream sequence of the human, mouse
and rat GCH1 genomes was performed using ClustalW (http://
www.ebi.ac.uk/Tools/clustalw/). Prediction of RNA secondary
structures within the human CFTR 5´ UTR mRNA was
performed using the mFold program, version 3.2 (http://
frontend.bioinfo.rpi.edu/applications/mfold/). The wild type
(+142C) and +142T 5’UTR GCH1 sequences were also
analyzed using the UTR site database (utrdb.ba.itb.cnr.it) to
detect any RNA protein binding motifs created or destroyed by
the +142C>T substitution. Finally, the 5’UTR-Fluc reporter
sequences and the human GCH1 mRNA sequence
(NM_000161.2) with either a +142C or a +142T were analyzed
on the NCBI ORF Finder (http://www.ncbi.nlm.nih.gov/projects/
gorf/) to detect potential uORFs.
Results
Alignment of the 5’ upstream sequence of the human, mouse
and rat GCH1 genes revealed that among the three point
5'UTR GCH1 Substitutions and DRD
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substitutions examined only the +142C is evolutionarily
conserved between the human, rat and mouse genome (Figure
1). All of the three 5’ upstream GCH1 substitutions fall within its
5’UTR (+142C>T; +125C>T; +32T>C; Figure 1) rendering it
more likely that any potential effects would involve post-
transcriptional mechanisms.
Effects of the GCH1 5’UTR substitution on the
luciferase reporter assay
We utilized a previously characterized GCH1 reporter
construct [27] encompassing 452 bps upstream of the
transcription start site (+1) and 163 bps corresponding to the
distance between the +1 and the translation start site ATG
(615GCH1/WT; Figure 2A). Three mutant reporter constructs
were generated to mimic the 5’UTR GCH1 reported
substitutions; 615GCH1/+142T, 615GCH1/+125T and
615GCH1/+32C (Figure 2A). Transient transfection assays
were performed in a human neuroblastoma SK-N-BE(2)-M17
cell line, a monoamine (MA) and BH4 containing cell line in
which the GCH1 promoter has been reported to be active [28].
Normalized Fluc activity for each of the mutant constructs
compared to the wild type (set at 100%) revealed that the
615GCH1/+142T construct caused a reduction in luciferase
activity to 32% of the 615GCH1/WT activity (n=4, P ≤ 0.005;
Figure 2.  Effects of the +142C>T, the +125C>T and the +32T>C 5’UTR GCH1 single nucleotide substitutions on luciferase
activity.  (A) Schematic representation of the luciferase reporter constructs bearing a 615 bp fragment of the 5’ upstream GCH1
region followed by the luciferase gene (Fluc) with either the wild type sequence (+32T/+125C/+142C) or the identified substitutions
(+142T, +125T, +32C or +32C/+125T). (B) SK-N-BE2-M17 cells were transiently transfected with each Fluc construct indicated in
the bottom of each graph bar and the CMV-Rluc. Results are shown as the mean ± S.E.M. of relative Fluc normalized to Rluc
activity. The % activity of each construct relative to the wild type (set as 100%) is indicated above each bar (n=4, Student’s t-test * =
P ≤ 0.005). (C) Schematic representation of the reporter constructs bearing a 5399 or a 615 bp fragment of the 5’ upstream GCH1
region followed by the Fluc with either a C (5399GCH1/WT and 615GCH1/WT) or a T (5399GCH1/+142T and 615GCH1/+142T) at
+142. (D SK-N-BE2-M17 cells were transiently transfected with each Fluc construct indicated in the bottom of each graph bar and
the CMV-Rluc. Results are shown as the mean ± S.E.M. of relative Fluc normalized to Rluc activity. The % activity of each construct
relative to the wild type (set as 100%) is indicated above each bar (n=4, Student’s t-test * = P ≤ 0.005).
doi: 10.1371/journal.pone.0076975.g002
5'UTR GCH1 Substitutions and DRD
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Figure 2B). Likewise, when the +142T substitution was
introduced in the larger 5399 bp reporter construct
(5399GCH1/WT and 5399GCH1/+142T, Figure 2C) luciferase
activity dropped to 37% of the wild type (n=4, P ≤ 0.005; Figure
2D). In contrast, the 615GCH1/+125T, the 615GCH1/+32C and
the double mutant 615GCH1/+125T/+32C constructs did not
result in a statistically significant reduction in luciferase activity
(94%, 89% and 90% of wild type activity, respectively, n=4;
Figure 2B). Finally, after generation of the +142T reporter
construct, we re-introduced the +142C in the
5399GCH1/+142T or the 615GCH1/+142T constructs and
luciferase activity returned to wild type levels (data not shown).
Effects of the +142C>T GCH1 substitution on luciferase
mRNA
We then analyzed the effects of the +142C>T substitution on
luciferase mRNA levels expressed in SK-N-BE(2)-M17 cells
transiently transfected with luciferase reporter constructs. QRT-
PCRs revealed no statistically significant differences between
the relative mRNA levels of the 615GCH1/WT (set to 100%)
and the 615GCH1/+142T (113%) reporter constructs (n=4;
Figure 3A). To determine if the +142C>T substitution affected
mRNA stability, inhibition of transcription was achieved with
ActinomycinD and luciferase mRNA half-lives were determined
to 4.1 hrs for the 615GCH1/WT and 4.3 hrs for the
615GCH1/+142T transcript. This difference in half-lives was not
statistically significant (n=3, Figure 3B).
Endogenous GCH1 levels in normal individuals and
DRD patients
We further investigated the effects of the +142C>T
substitution on in vivo GCH1 mRNA levels by qRT-PCR
analysis in lymphoblastoid cultures established from DRD
patients and control individuals. While the average relative
steady-state levels of GCH1 mRNA were lower in DRD patients
(0.842) compared to controls (set at 1.0), this reduction was not
statistically significant (n=4; Figure 4A). Furthermore, when
transcription was inhibited by actinomycinD, there was no
statistically significant difference in the GCH1 transcript half-life
between DRD and control subjects (11.4 hrs in controls vs 11.8
hrs in patients), (n=3; Figure 4B).
Bioinformatics analysis
RNA secondary structures analysis, performed for the
complete 5’UTR GCH1 region with either a C or a T at +142
predicted no structural differences between them (Figure 5).
Since our experimental data did not reveal evidence for
transcriptional effects of the +142C>T substitution, we scanned
the wild type GCH1 +142C and the GCH1 +142T 5’UTRs for
RBP motifs and found no differences (data not shown).
However, we observed that the +142C>T substitution created a
novel upstream ATG codon (ACG>ATG) (Figure 6). Indeed,
scanning the 5’UTR-coding GCH1 sequence with the NCBI
ORF Finder software revealed that in presence of a T at +142,
an uATG arises and a potential upstream open reading frame
(uORF) (sequence in bold; Figure 6), starting 23 nucleotides
Figure 3.  Effects of the +142C>T GCH1 substitution on the steady-state luciferase mRNA level and its stability.  (A) Steady-
state levels of Fluc/Rluc mRNA in SK-N-BE2-M17 cells transiently transfected with either the 615GCH1/WT or 615GCH1/+142T
Fluc and the CMV-Rluc construct. Normalized Fluc Ct values were converted to relative mRNA levels and results are shown as
mean ± S.E.M (615GCH1/WT, set at 100%) (n=4). (B) SK-N-BE2-M17 cells were transiently transfected as above and treated with
ActinomycinD. RNA was collected at 0, 2, 4 and 6 hrs and subjected to qRT-PCR. Normalized Fluc Ct values were converted to
relative mRNA levels and results are shown as means ± S.E.M. plotted to a linear regression over time, with time zero set to 100%.
Half-lives were calculated based on the slope and intercept; t♦1/2= 4.1hrs for the 615GCH1/WT construct and t•1/2= 4.3hrs for the
615GCH1/+142T construct (n=3).
doi: 10.1371/journal.pone.0076975.g003
5'UTR GCH1 Substitutions and DRD
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upstream of the physiological ATG (underlined; Figure 6) and
terminating after 219 bases at a STOP codon within an exon of
the wild type GCH1 sequence (TGA circled; Figure 6). Thus,
the +142C>T substitution is likely to result in production of a 73
amino acid peptide
(MAAAAAGPWRRALCGHRRRSRGAPGAAMGSPSGIRRGPG
PAGRRRSPRGPRPRARSPRTAGRASGPAARRITS) which is
out of frame with the pATG codon initiating translation of the
physiological GCH1 protein (Figure 6). Note that for the 5’UTR
GCH1-luciferase constructs used in this study, sequence
scanning by the NCBI ORF Finder software showed that the
newly generated uORF would encode an out of frame of 14aa
truncated peptide (analysis non shown).
Discussion
In eukaryotes, regulation of protein synthesis is a finely-
tuned process involving multiple steps of transcription,
posttranscriptional processing and modification, mRNA
stability, translation initiation and posttranslational modification.
Human disease can result from single nucleotide
polymorphisms that affect any step of this finely tuned
regulatory system. In particular for diseases linked to non-
coding substitutions, functional assays are required to establish
a link between the substitution and the disease phenotype. In
DRD, three different sequence substitutions have been
identified within the 5’ untranslated region of the GCH1 gene
[16–18]. We demonstrated here that the +125C>T and the
+32T>C substitutions reported together in a single DRD patient
had negligible effects on luciferase activity when tested either
individually or combined into a single reporter construct. The
presence of these substitutions has been examined in only 3
neurologically normal subjects, who did not harbor either or
both substitutions [17]. In contrast, the +142C>T substitution
which segregates with affected status in ten members of a
single DRD family, spanning three generations but not found in
a total of 543 control alleles [18], had a strong negative effect,
leading to a 68% reduction in luciferase activity. The effect
persisted even when the +142T substitution was introduced
into the larger 5399GCH1 reporter construct having a greater
degree of endogenous transcriptional regulation. To ensure
that no random mutations within the luciferase vector backbone
affected our results, we re-introduced the wild type +142C back
onto the mutant +142T construct and luciferase activity
returned to wild type levels. To our knowledge, no gene
dosages studies of the +142C>T substitution carriers has been
conducted.
We next investigated if the +142T-triggered reduction in
luciferase activity was mediated by a reduction in luciferase
mRNA levels. We found that the +142T had no significant
effect on luciferase mRNA abundance. Furthermore, RNA
decay kinetics demonstrated a similar mRNA half-life for both
the +142C and the +142T 5’UTR luciferase reporter constructs.
Similarly, there was no statistically significant difference in
endogenous steady-state GCH1 mRNA levels or its stability in
lymphoblastoid cells derived from DRD and control subjects.
Figure 4.  GCH1 mRNA levels and stability in lymphoblastoid cells from DRD and control subjects.  (A) Steady-state levels of
GCH1 mRNA in lymphoblastoid cells derived from six DRD subjects and six control subjects. Normalized GCH1 Ct values were
converted to relative mRNA levels. Box plots show mean ± S.E.M. of the control and DRD GCH1 mRNA levels (n=4). (B)
Lymphoblastoid cultures from DRD and control subjects were exposed to ActinomycinD, RNA was collected at 0, 6, 12 and 24 hrs
and subjected to qRT-PCR. Normalized GCH1 Ct values were converted to relative mRNA levels and results are shown as means ±
S.E.M. plotted to a linear regression over time, with time zero set at 100%. Half-lives were calculated based on the slope and
intercept; t♦1/2=11.4hrs for control and t•1/2= 11.8hrs for DRD subjects (n=3).
doi: 10.1371/journal.pone.0076975.g004
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Cerebrospinal fluid from these patients was not available to
assess the BH4 level but previous studies support that altered
GCH1 mRNA levels can be detected in mononuclear blood
cells from DRD patients with coding GCH1 mutations [29]. In
agreement with our experimental data, bioinformatics analysis
predicted the same RNA structure in the presence of a +142C
or a +142T within the GCH1 5’UTR. Taken together these
results support that the +142C>T GCH1 5’UTR substitution
alters efficiency of translation without affecting RNA levels or
RNA stability/structure.
Scanning of the wild type +142C and the +142T GCH1 5´
UTR sequences predicted no differences in RBP sites. Thus, it
is unlikely that differences between RBP association with the
wild type and the 142T 5’UTR sequences are the cause of the
observed changes in translation. An alternate level of
translational regulation involves the creation of uAUGs and
uORFs [25]. Genes can be devoid of uAUGs or bear a single or
several uAUGs which mediate complete or partial inhibition of
the physiological AUG (pAUG) [22,25,30]. Our in silico analysis
revealed that the wild type 5’UTR GCH1 region lacks of any
uAUG. However, the +142T substitution introduces a single
uAUG and a potential uORF encoding a truncated, out of
frame, peptide. The +142T substitution results in reduced
luciferase activity indicating that both the truncated and full
length luciferase protein are generated, with the truncated
peptide competing for efficiency of translation against the full
length peptide.
These results do not provide direct evidence of the effects of
the +142T substitution on the GCH1 levels in DRD patients.
However, similar to the luciferase constructs, the +142T may
generate an uORF that encodes a 73 aa out of frame peptide
that competes with the translation of wild type GCH1 initiated
by the pAUG. A model in which a mixture of wild type and
truncated peptides are generated in a competitive manner due
to creation of novel uAUGs has been reported in human
diseases ranging from a predisposition to cancer [31] to
bronchiectasis [32] and bipolar depression [33]. Our study
expands this list to include dystonia by revealing that the
+142C>T GCH1 5’UTR substitution detected in DRD patients is
a functional mutation that reduces translational efficiency and
likely leads to reduced wild type GCH1 protein levels,
underlying manifestation of DRD.
Figure 5.  Computer-assisted RNA secondary structures for the +142C and the +142T GCH1 5 upstream region.  Mfold
analysis predicted same RNA secondary structure regardless of a +142C (up) or a +142T (bottom) within the GCH1 5’UTR. The
position of the +142C>T substitution is indicated with an arrow.
doi: 10.1371/journal.pone.0076975.g005
5'UTR GCH1 Substitutions and DRD
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Figure 6.  The GCH1 5’UTR and Coding region.  Normal translation starts at the underlined ATG and ends at the underlined TGA
stop codon. The rectangle indicates the point of the +142C>T substitution and the bases in bold indicate the out of frame uORF
initiated by the uATG and ending at a TGA triplet (bold, circled) within the coding region of the normal sequence.
doi: 10.1371/journal.pone.0076975.g006
5'UTR GCH1 Substitutions and DRD
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